PROMACTA 25 mg/1 (Eltrombopag Olamine POWDER, FOR SUSPENSION) 25 mg/1

PROMACTA 25 mg/1 is an oral suspension powder containing eltrombopag olamine, used to support platelet production. This medication is designed for patients requiring platelet support, offering a convenient powder form for oral administration.

Strength

25 mg/1

Pack Size

1 CARTON in 1 KIT (0078-0697-61) / 30 PACKET in 1 CARTON (0078-0697-23) / 1 POWDER, FOR SUSPENSION

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PROMACTA 25 mg/1 is primarily used to support platelet production in the body. It is often prescribed for conditions where low platelet counts are a concern, helping to maintain healthy levels. The medication is formulated as a powder for suspension, making it easy to administer orally. Patients and healthcare providers may explore 'what is PROMACTA used for' to understand its role in managing platelet-related issues.

Side Effects

PROMACTA 25 mg/1 works by stimulating the production of platelets in the bone marrow. Common effects may include an increase in platelet counts, which can help reduce the risk of bleeding. Some users may experience mild gastrointestinal discomfort or other common side effects associated with oral medications.

Precautions & Warnings

PROMACTA 25 mg/1 should be handled with care, following the instructions provided by healthcare professionals. It is important to store the medication properly and use it as directed. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting this treatment.

Avoid Interactions

PROMACTA 25 mg/1 may interact with certain medications, including those that affect liver enzymes or other oral medications. It is advisable to consult a healthcare provider before combining PROMACTA with other treatments. Alcohol and certain foods may also impact the effectiveness of the medication.

Frequently Asked Questions

PROMACTA 25 mg/1 is used to support platelet production in the body, often prescribed for conditions where low platelet counts are a concern.

PROMACTA 25 mg/1 is administered orally as a powder for suspension, following the instructions provided by healthcare professionals.

Common effects may include an increase in platelet counts, which can help reduce the risk of bleeding. Some users may experience mild gastrointestinal discomfort.

Patients should inform their healthcare provider about any existing medical conditions or allergies before starting PROMACTA 25 mg/1.

PROMACTA 25 mg/1 may interact with certain medications, including those that affect liver enzymes or other oral medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.